Task: Answer the multiple-choice question.
Question: Which drug exhibits a 4.386% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a Cc1ccccc1-c1nn(-c2ccc(F)cc2F)cc1CNC1CC1
b COc1ccccc1CCNC(=O)CCn1nc(C)c2c(C)n(-c3ccccc3)nc2c1=O
c CC(=O)N1CCCc2ccccc21
Answer: a. Cc1ccccc1-c1nn(-c2ccc(F)cc2F)cc1CNC1CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1-c1nn(-c2ccc(F)cc2F)cc1CNC1CC1
Cc1ccccc1-c1nn(-c2ccc(F)cc2F)cc1CNC1CC1
N-[[1-(2,4-difluorophenyl)-3-(2-methylphenyl)pyrazol-4-yl]methyl]cyclopropanamine